Mapping of Glycine Distributions in Gliomas

References

1. 1.↵
   1. Banerjee A,
   2. Ganji S,
   3. Hulsey K,
   4. et al

   . Measurement of glycine in gray and white matter in the human brain in vivo by 1H MRS at 7.0 T. Magn Reson Med 2012;68:325–31

   CrossRefPubMed
2. 2.↵
   1. Mader I,
   2. Roser W,
   3. Hagberg G,
   4. et al

   . Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors. MAGMA 1996;4:139–50

   CrossRefPubMed
3. 3.↵
   1. Hattingen E,
   2. Lanfermann H,
   3. Quick J,
   4. et al

   . 1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumours. MAGMA 2009;22:33–41

   CrossRefPubMed
4. 4.↵
   1. Choi C,
   2. Ganji SK,
   3. DeBerardinis RJ,
   4. et al

   . Measurement of glycine in the human brain in vivo by 1H-MRS at 3 T: application in brain tumors. Magn Reson Med 2011;66:609–18

   CrossRefPubMed
5. 5.↵
   1. Candiota AP,
   2. Majos C,
   3. Julia-Sape M,
   4. et al

   . Non-invasive grading of astrocytic tumours from the relative contents of myo-inositol and glycine measured by in vivo MRS. JBR-BTR 2011;94:319–29

   PubMed
6. 6.↵
   1. Wright AJ,
   2. Fellows GA,
   3. Griffiths JR,
   4. et al

   . Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers. Mol Cancer 2010;9:66

   CrossRefPubMed
7. 7.↵
   1. Righi V,
   2. Andronesi OC,
   3. Mintzopoulos D,
   4. et al

   . High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors. Int J Oncol 2010;36:301–06

   PubMedWeb of Science
8. 8.↵
   1. Davies NP,
   2. Wilson M,
   3. Natarajan K,
   4. et al

   . Non-invasive detection of glycine as a biomarker of malignancy in childhood brain tumours using in-vivo 1H MRS at 1.5 Tesla confirmed by ex-vivo high-resolution magic-angle spinning NMR. NMR Biomed 2010;23:80–87

   CrossRefPubMed
9. 9.↵
   1. Roy B,
   2. Gupta RK,
   3. Maudsley AA,
   4. et al

   . Utility of multiparametric 3T MRI for glioma characterization. Neuroradiology 2013;55:603–13

   CrossRefPubMed
10. 10.↵
    1. Gambarota G,
    2. Mekle R,
    3. Xin L,
    4. et al

    . In vivo measurement of glycine with short echo-time 1H MRS in human brain at 7 T. MAGMA 2009;22:1–4

    PubMed
11. 11.↵
    1. Maudsley AA,
    2. Domenig C,
    3. Govind V,
    4. et al

    . Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI). Magn Reson Med 2009;61:548–59

    CrossRefPubMed
12. 12.↵
    1. Maudsley AA,
    2. Darkazanli A,
    3. Alger JR,
    4. et al

    . Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging. NMR Biomed 2006;19:492–503

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Zhang X,
    2. Heberlein K,
    3. Sarkar S,
    4. et al

    . A multiscale approach for analyzing in vivo spectroscopic imaging data. Magn Reson Med 2000;43:331–34

    CrossRefPubMed
14. 14.↵
    1. Awasthi R,
    2. Verma SK,
    3. Haris M,
    4. et al

    . Comparative evaluation of dynamic contrast-enhanced perfusion with diffusion tensor imaging metrics in assessment of corticospinal tract infiltration in malignant glioma. J Comput Assist Tomogr 2010;34:82–88

    CrossRefPubMed
15. 15.↵
    1. Shank RP,
    2. Aprison MH

    . The metabolism in vivo of glycine and serine in eight areas of the rat central nervous system. J Neurochem 1970;17:1461–75

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Jain M,
    2. Nilsson R,
    3. Sharma S,
    4. et al

    . Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 2012;336:1040–44

    Abstract/FREE Full Text
17. 17.↵
    1. Liu J,
    2. Guo S,
    3. Li Q,
    4. et al

    . Phosphoglycerate dehydrogenase induces glioma cells proliferation and invasion by stabilizing forkhead box M1. J Neurooncol 2013;111:245–55

    CrossRefPubMed
18. 18.↵
    1. Locasale JW,
    2. Grassian AR,
    3. Melman T,
    4. et al

    . Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 2011;43:869–74

    CrossRefPubMed
19. 19.↵
    1. Possemato R,
    2. Marks KM,
    3. Shaul YD,
    4. et al

    . Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011;476:346–50

    CrossRefPubMedWeb of Science